Today: 10 June 2026
Browse Category

NYSE:KVUE 14 October 2025 - 9 November 2025

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kenvue (NYSE: KVUE) Stock Surges on $40B Buyout – Spin‑Off Saga, Tylenol Turmoil & Investor Outlook

Kimberly-Clark agreed to acquire Kenvue for $48.7 billion on Nov. 3, 2025, a 46% premium to its prior close. Kenvue shares surged nearly 20% on the news, while Kimberly-Clark stock dropped 13%. The deal follows a turbulent year for Kenvue, including a CEO ouster, falling sales, and litigation over Tylenol safety claims. Kenvue posted $15 billion in 2025 revenue and maintained gross margins near 59%.
Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark’s $40 Billion Gamble Sends KMB Stock Plunging – What’s Next for This Dividend King?

Kimberly-Clark shares plunged 14.6% on Nov. 3 to a 52-week low near $102 after announcing a $40 billion cash-and-stock deal to acquire Kenvue at a 46% premium. The drop erased about 15% of KMB’s market value, with the stock now down 21% year-over-year. Investors cited concerns over Kenvue’s litigation risks and debt load. KMB trades at 17.3× earnings, with a 4.9% dividend yield.
4 November 2025
Kenvue (KVUE) Stock Soars 20% on $48.7 B Buyout News – Q3 Earnings Beat and What’s Next

Kenvue (KVUE) Stock Soars 20% on $48.7 B Buyout News – Q3 Earnings Beat and What’s Next

Kimberly-Clark announced a $48.7 billion cash-and-stock deal to acquire Kenvue, sending Kenvue shares up about 20% in pre-market trading to near $17.50. Kenvue shareholders will receive $3.50 in cash and 0.14625 KMB shares per KVUE share. Kenvue reported Q3 net profit of $398 million, beating earnings expectations. Kimberly-Clark shares fell roughly 12.5% on the news.
Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue shares plunged 13% Thursday to a record low near $14 after news of U.K. lawsuits over Johnson’s Baby Powder, representing 3,000 claimants and potential £1 billion in damages. The stock is down about 34% year-to-date and nearly 40% below its IPO price. Wall Street cut price targets and Moody’s downgraded its outlook to “negative.” Kenvue’s market cap now stands at roughly $30–31 billion.
Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue shares hit a 52-week low of $15.46 on Oct. 16, 2025, down about 5% in one day and over 27% in the past year. The company faces new UK talcum-powder lawsuits and ongoing FDA scrutiny over Tylenol, while Q2 revenue fell 4% to $3.84 billion. Moody’s affirmed its A1 rating but cut the outlook to negative. Kenvue replaced its CEO in July and launched a strategic review, considering asset sales.
16 October 2025
J&J Makes Bold Move: Orthopedics Spin-Off (“DePuy Synthes”) Announced – 2025 Forecast Raised

J&J Makes Bold Move: Orthopedics Spin-Off (“DePuy Synthes”) Announced – 2025 Forecast Raised

Johnson & Johnson will spin off its $9.2 billion orthopedics business as DePuy Synthes within 18–24 months, its second major split since 2023. J&J beat Q3 2025 earnings estimates, raised its full-year revenue outlook to up to $93.9 billion, and saw shares rise 2% on Oct. 14. The move shifts J&J’s focus to higher-growth drug and device segments. CFO Joe Wolk said orthopedics innovation was “in better hands somewhere else.”
14 October 2025

Stock Market Today

  • Top ASX Penny Stocks to Watch in June 2026: Boom Logistics and Cogstate
    June 9, 2026, 10:32 PM EDT. Amid Australian market weakness and recession fears, ASX penny stocks offer growth potential. Boom Logistics (ASX:BOL), with a market cap of A$74.16 million, generates A$275.08 million from lifting solutions in mining and infrastructure. Despite recent negative earnings growth, forecasts project 20.96% annual growth and a strengthened financial position under new CFO Pieter Le Roux. Cogstate Limited, valued at A$442 million, specializes in digital brain health assessments, showing robust revenue and a 46.7% earnings increase last year. Debt-free with strong assets, Cogstate is expanding sales in Psychiatry and Narcolepsy sectors. These firms exemplify promising opportunities in smaller-cap ASX stocks with improving fundamentals and strategic advancements.

Latest articles

Nasdaq Sees More Moves After Hours Following U.S. Strike on Iran

Nasdaq Sees More Moves After Hours Following U.S. Strike on Iran

10 June 2026
U.S. stock futures fell after hours and oil rose as U.S. strikes on Iran fueled risk-off sentiment, deepening losses in tech shares and raising investor caution ahead of Wednesday’s key inflation report, with fears of Fed rate hikes and volatility from the upcoming SpaceX IPO adding pressure.
Keel Slides After $458 Million AI Data-Center Debt Deal Launch

Keel Slides After $458 Million AI Data-Center Debt Deal Launch

10 June 2026
Keel Infrastructure shares plunged 4.24% to $5.42 after closing a $458 million convertible debt sale, reviving investor fears of future dilution even as the company boosts funding for AI-focused data-center projects; shares slipped further to $5.32 after hours on more than double average volume, reflecting concerns over execution risks and the impact of new financing.
Super Micro sinks after $7B AI server plan; dilution a risk

Super Micro sinks after $7B AI server plan; dilution a risk

10 June 2026
Super Micro Computer plans to raise $7 billion through equity and equity-linked financing to fund soaring AI server orders, sending shares down about 9% in after-hours trading as investors focused on dilution risk; the company reported $39 billion in recent AI server orders, but noted these are not firm commitments and cited ongoing legal and regulatory risks.
American Airlines Stock Rises on Google Fuel Deal, Market Watches for Fuel Shock

American Airlines Stock Rises on Google Fuel Deal, Market Watches for Fuel Shock

10 June 2026
American Airlines surged to $14.09, up 48.5 cents, after announcing a three-year sustainable aviation fuel deal with Google covering 35 million gallons, as investors focused on surging fuel costs that jumped 78% in April to $6.5 billion; the stock rose in line with airline peers amid a drop in crude prices, while American’s 2026 outlook remains pressured by higher fuel expenses and a narrowed profit forecast.
Nokia Drops 7% After Nvidia 6G Chatter Hits AI Stocks

Nokia Drops 7% After Nvidia 6G Chatter Hits AI Stocks

10 June 2026
Nokia shares plunged 6.99% to 11.970 euros in Helsinki after reports of Nvidia’s push into future mobile-network tech raised fears over Nokia’s AI-driven growth story, with investors questioning whether Nokia can maintain its edge as competition intensifies and its forward P/E more than doubles this year.
Go toTop